GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Everest Medicines 1952.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

26.18

-3.11%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Everest Medicines

Our reporting

Next results

1 Apr 2027

Due on 1 Apr 2027. Analysts expect earnings of 2.19 a share on revenue of CN¥2.49bn.

Past results

Reported against what analysts expected

17 Aug 202624 Mar 202627 Aug 202524 Mar 202527 Aug 202428 Jun 2024
Earnings per share-0.02-0.13-0.84-1.35-2.12-1.06
Forecast-1.070.11-1.11-1.34-1.09—
RevenueCN¥1.32bnCN¥1.40bnCN¥488.9mCN¥431.2mCN¥324.0mCN¥163.1m
ForecastCN¥1.59bnCN¥1.41bnCN¥598.2mCN¥431.4mCN¥271.5m—

Key events

  1. 9 Oct 2020Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.